IAVI R001

Phase:
I
Status:
Completed
Candidates:
rcAd26.MOS1.HIVEnv
Countries:
United States
Volunteers:
24
Partners:

University of Rochester; Beth Israel Deaconess Medical Center

Phase 1 Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine

ClinicalTrials.gov Identifier: NCT02366013